Cargando…
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation
Oncogenic KRAS is the key driver oncogene for several of the most aggressive human cancers. One key feature of oncogenic KRAS expression is an early increase in cellular reactive oxygen species (ROS) which promotes cellular transformation if cells manage to escape cell death, mechanisms of which rem...
Autores principales: | Müller, Fabienne, Lim, Jonathan K. M., Bebber, Christina M., Seidel, Eric, Tishina, Sofya, Dahlhaus, Alina, Stroh, Jenny, Beck, Julia, Yapici, Fatma Isil, Nakayama, Keiko, Torres Fernández, Lucia, Brägelmann, Johannes, Leprivier, Gabriel, von Karstedt, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950476/ https://www.ncbi.nlm.nih.gov/pubmed/36443441 http://dx.doi.org/10.1038/s41418-022-01096-8 |
Ejemplares similares
-
Ferroptosis in Cancer Cell Biology
por: Bebber, Christina M., et al.
Publicado: (2020) -
Phase separation of FSP1 promotes ferroptosis
por: Nakamura, Toshitaka, et al.
Publicado: (2023) -
Non-neuroendocrine differentiation generates a ferroptosis-prone lipidome in small cell lung cancer (SCLC)
por: Bebber, Christina M., et al.
Publicado: (2021) -
Structural insights into FSP1 catalysis and ferroptosis inhibition
por: Lv, Yun, et al.
Publicado: (2023) -
Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation
por: Nakamura, Toshitaka, et al.
Publicado: (2023)